Clinical complexity in middle-aged and older adults with diabetes: The health and retirement study

Medical Care

Volumn 48, Issue 4, 2010, Pages 327-334

  Blaum, Caroline S ^a   Cigolle, Christine T ^b   Boyd, Cynthia ^c   Wolff, Jennifer L ^d   Tian, Zhiyi ^e   Langa, Kenneth M ^b   Weir, David R ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Purdue University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HEALTH STATUS; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF CARE; UNITED STATES; VISUAL IMPAIRMENT;

AGED; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCEMIC INDEX; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; SELF CARE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; UNITED STATES;

EID: 77950294228     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181ca4035     Document Type: Article

References (25)

1. Center for Disease Control. Diabetes surveillance 2009. Available at: http://www.cdc.gov/diabetes/statistics/incidence-national.htm. Accessed April 17 2009.
2. Center for Disease Control. Prevalence of diabetes by age 2008. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/ figbyage.htm. Accessed April 17 2009.
3. UK Prospective Diabetes Study Group. A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. (UKPDS 28). Diabetes Care. 1998;21:87-92
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
5. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
6. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
7. Blaum CS, Ofstedal MB, Langa KM, et al. Functional status and health outcomes in older Americans with diabetes mellitus. J Am Geriatr Soc. 2003;51:745-753.
8. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725-731.
9. Buse JB, Bigger JT, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Car-diol. 2007;99:21i-33i.
10. Goff DC Jr, Gerstein HC, Ginsberg HN, et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:4i-20i.
11. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet. 2007;370:829-840.
12. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes. N Engl J Med. 2008;358:2560-2572.
13. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716-724.
14. Heisler M, Faul JD, Hayward RA, et al. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167: 1853-1860.
15. Heisler M, Smith DM, Hayward RA, et al. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care. 2003;41: 1221-1232.
16. Juster FT, Suzman RM. An overview of the health and retirement study. J Human Res. 1995;30:S7-S56.
17. Blaum CS, Ofstedal MB, Liang J. Low cognitive performance, comorbid disease, and task-specific disability: findings from a nationally representative survey. J Gerontol A Biol Sci Med Sci. 2002;57:M523-M531.
18. Herzog AR, Wallace RB. Measures of cognitive functioning in the AHEAD study. J Gerontol B Psychol Sci Soc Sci. 1997;52(Spec No): 37-48.
19. Langa KM, Chernew ME, Kabeto MU, et al. National estimates of the quantity and cost of informal care giving for the elderly with dementia. J Gen Intern Med. 2001;16:770-778.
20. Langa KM, Larson EB, Karlawish JH, et al. Trends in the prevalence and mortality of Alzheimer's disease in the United States. Alzheimers Dement. 2008;4:1-44.
21. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2008;31:S12-S54.
22. StataCorp. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP; 2005.
23. Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(suppl 5):S265-S280.
24. Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA. 2006;295:1935-1940.
25. Association of American medical colleges. The Medical Home 2008. Available at: http://www.aamc.org/newsroom/pressrel/2008/medicalhome.pdf. Accessed May 7 2009.